CN103866019B - Y-STR fluorescent composite amplification testing reagent - Google Patents
Y-STR fluorescent composite amplification testing reagent Download PDFInfo
- Publication number
- CN103866019B CN103866019B CN201410087742.2A CN201410087742A CN103866019B CN 103866019 B CN103866019 B CN 103866019B CN 201410087742 A CN201410087742 A CN 201410087742A CN 103866019 B CN103866019 B CN 103866019B
- Authority
- CN
- China
- Prior art keywords
- primer
- sequence
- increases
- str
- sequence table
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses Y-STR fluorescent composite amplification testing reagent.The invention provides DNA and check primer sets, comprise the primer pair group for following 21 Y-STR sites of increasing.Experiment of the present invention proves, DNA detection reagent provided by the invention, 21 Y-STR sites can be checked simultaneously, and primer specificity is high, complete STR somatotype can be obtained, and peak type is sharply clear, balance is good, without Pull-up peak, stutter band, specificity artifact occurs nothing but, can meet the requirement that legal medical expert Y-STR checks completely.
Description
Technical field
The present invention relates to biological technical field, particularly relate to a kind of reagent for human Y-chromosome DNA inspection and primer special, be specifically related to Y-STR fluorescent composite amplification inspection examination.
Background technology
DNA inspection technology especially (ShortTandemRepeats) STR detection technique, since 20th century, the mid-80 came out, has all played huge effect in criminal, civil case, large-scale catastrophic failure (as: U.S.'s the September 11th attacks, Indonesia's tsunami, Wenchuan violent earthquake) and mass unexpected incident.STR (STR), also known as microsatellite DNA (microsatelliteDNA), STR detection technique is mainly by detecting the polymorphism in these specificity STR sites, after the information obtaining multiple corresponding STR site, carry out the parallel comparison of multidigit dot information, thus achieve individual recognition and paternity identification.STR detects with its distinctive technical superiority, is focus and the core of medicolegal genetics research in decades always, and is widely used in multiple fields such as medical jurisprudence individual recognition and paternity test.Forensic DNA typing standard committee of European Union is thought, although new technology and new genetic marker continue to bring out, within period quite long from now on, STR will remain topmost human specific genetic marker.
Human Y-chromosome is not recombinated with other karyomit(e) in genetic process, and sequence structure feature can stably be handed down from father to son and by the male sex peculiar, there is paternal inheritance feature.Male participation is had in most of case of violence and all rape offenders.Therefore, the effect of Y-STR in forensic science manifests gradually.When there is no the paternity determination of father, utilizing the paternal inheritance feature of Y chromosome str locus seat (Y-STR), can be identified by paternal relative.In mixed stain qualification, when particularly cannot be separated by two-step approach, Y-STR has more advantage.In gang-rape case, Y-STR is for determining that criminal's number also has great role.In addition, because Y-STR has patroclinous feature, the colony of not agnate, different areas, the distribution of Y-STR also exists otherness, can disclose the race of suspect, residence or even surname to its somatotype.
In recent years, along with the develop rapidly of Protocols in Molecular Biology, increasing Y-STR is developed and utilizes.1997, the first time such as Prinz established Y-STR composite amplification system, called after QuadruplexI, marks DYS19, DYS389I, DYS389II and DYS390 respectively, and done forensic application Journal of Sex Research with two kinds of fluorescence JOE and FAM.American AB I (AppliedBiosystems) company is proposed Y-Filer test kit, comprises 17 Y-STR sites such as DYS456, DYS389I, DYS389II, DYS390, DYS458, DYS19, DYS385, DYS393, DYS391, DYS439, DYS635, DYS392, YGATA-H4, DYS437, DYS438, DYS448.Promega company of the U.S. also develops the PowerPlexY test kit comprising 12 Y-STR sites such as DYS391, DYS389I, DYS439, DYS389II, DYS438, DYS437, DYS19, DYS392, DYS393, DYS390, DYS385a/b.These Y-STR test kits play increasing effect in forensic dna inspection field.
Along with the development of micro-Y chromosome STR inspection technology, its range of application has the trend expanded further, as the quick investigation of Y-DNA database establishment and extensive sample.
Summary of the invention
An object of the present invention is to provide a kind of DNA and check primer sets.
DNA provided by the invention checks primer sets, comprises the primer pair group for following 21 Y-STR sites of increasing;
The described primer pair group for following 21 Y-STR sites of increasing is as follows:
For the primer pair of the Y-STR site DYS460 that increases, it is made up of the primer 2 shown in sequence 2 in the primer 1 shown in sequence in sequence table 1 and sequence table;
For the primer pair of the Y-STR site DYS458 that increases, it is made up of the primer 4 shown in sequence 4 in the primer 3 shown in sequence in sequence table 3 and sequence table;
For the primer pair of increase Y-STR site DYS389I or Y-STR site DYS389II, it is made up of the primer 6 shown in sequence 6 in the primer 5 shown in sequence in sequence table 5 and sequence table;
For the primer pair of the Y-STR site DYS438 that increases, it is made up of the primer 8 shown in sequence 8 in the primer 7 shown in sequence in sequence table 7 and sequence table;
For the primer pair of the Y-STR site DYS390 that increases, it is made up of the primer 10 shown in sequence 10 in the primer 9 shown in sequence in sequence table 9 and sequence table;
For the primer pair of the Y-STR site DYS392 that increases, it is made up of the primer 12 shown in sequence 12 in the primer 11 shown in sequence in sequence table 11 and sequence table;
For the primer pair of the Y-STR site DYS393 that increases, it is made up of the primer 14 shown in sequence 14 in the primer 13 shown in sequence in sequence table 13 and sequence table;
For the primer pair of the Y-STR site DYS437 that increases, it is made up of the primer 16 shown in sequence 16 in the primer 15 shown in sequence in sequence table 15 and sequence table;
For Y-STR site DYS385a or the primer pair for the Y-STR site DYS385b that increases of increasing, it is made up of the primer 18 shown in sequence 18 in the primer 17 shown in sequence in sequence table 17 and sequence table;
For the primer pair of the Y-STR site YGATA_H4 that increases, it is made up of the primer 20 shown in sequence 20 in the primer 19 shown in sequence in sequence table 19 and sequence table;
For the primer pair of the Y-STR site DYS391 that increases, it is made up of the primer 22 shown in sequence 22 in the primer 21 shown in sequence in sequence table 21 and sequence table;
For the primer pair of the Y-STR site DYS447 that increases, it is made up of the primer 24 shown in sequence 24 in the primer 23 shown in sequence in sequence table 23 and sequence table;
For the primer pair of the Y-STR site DYS19 that increases, it is made up of the primer 26 shown in sequence 26 in the primer 25 shown in sequence in sequence table 25 and sequence table;
For the primer pair of the Y-STR site DYS448 that increases, it is made up of the primer 28 shown in sequence 28 in the primer 27 shown in sequence in sequence table 27 and sequence table;
For the primer pair of the Y-STR site DYS456 that increases, it is made up of the primer 30 shown in sequence 30 in the primer 29 shown in sequence in sequence table 29 and sequence table;
For the primer pair of the Y-STR site DYS635 that increases, it is made up of the primer 32 shown in sequence 32 in the primer 31 shown in sequence in sequence table 31 and sequence table;
For the primer pair of the Y-STR site DYS439 that increases, it is made up of the primer 34 shown in sequence 34 in the primer 33 shown in sequence in sequence table 33 and sequence table;
For Y-STR site DYS527a or the primer pair for the Y-STR site DYS527b that increases of increasing, it is made up of the primer 36 shown in sequence 36 in the primer 35 shown in sequence in sequence table 35 and sequence table.
In above-mentioned primer sets,
Described primer 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, the mol ratio of 36 is 0.12:0.12:0.2:0.2:0.65:0.65:0.45:0.45:0.25:0.25:0.6:0.6: 0.15:0.15:0.2:0.2:0.35:0.35:0.4:0.4:0.25:0.25:0.45:0.45: 0.2:0.2:0.25:0.25:0.4:0.4:0.45:0.45:0.60:0.60:0.80:0.80.
The equal independent packaging of each bar primer in each primer pair described.
The mol ratio when mol ratio of above-mentioned primer is use.
In above-mentioned primer sets, a primer in primer pair described in each all uses fluorescent mark.
In above-mentioned primer sets, 5 ' end of the described primer 1 for the Y-STR site DYS460 that increases, for 5 ' end of the primer 3 of the Y-STR site DYS458 that increases, 5 ' end for the primer 5 of increase Y-STR site DYS389I or Y-STR site DYS389II, the 5 ' end for the primer 7 of the DYS438 that increases, the primer 9 for the DYS390 that increases 5 ' end and all mark with FAM for 5 ' end of the primer 11 of the DYS392 that increases;
5 ' end of the described primer 13 for the DYS393 that increases, 5 ' end of the described primer 15 for the DYS437 that increases, described for increasing Y-STR site DYS385a or all mark with HEX for 5 ' end of the primer 17 of the Y-STR site DYS385b that increases, 5 ' end of the described primer 19 for the YGATA_H4 that increases.
5 ' end of the described primer 37 for the Amelogenin that increases, 5 ' end of the described primer 21 for the DYS391 that increases, 5 ' end of the described primer 23 for the DYS447 that increases, 5 ' end of the described primer 25 for the DYS19 that increases, 5 ' end of the described primer 27 for the DYS448 that increases all mark with TAMRA;
5 ' end of 5 ' end of the described primer 29 for the DYS456 that increases, 5 ' end of the described primer 31 for the DYS635 that increases, the described primer 33 for the DYS439 that increases, the described 5 ' end for increase Y-STR site DYS527a or the primer 35 for the Y-STR site DYS527b that increases.
In above-mentioned primer sets, each bar primer of described primer sets is independent packaging.
Another object of the present invention is to provide a kind of DNA testing reagent.
DNA detection reagent provided by the invention, by above-mentioned primer sets, dNTP, MgCl
2, BSA, archaeal dna polymerase and water composition.
In above-mentioned DNA detection reagent, be describedly 0.12 μM for the final concentration of each bar primer in described reagent increased in the primer pair of DYS460;
For the DYS458 that increases primer pair in the final concentration of each bar primer in described reagent be 0.20 μM;
0.65 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS389I or DYS389II;
0.45 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS438;
0.25 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS390;
0.60 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS392;
0.15 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS393;
0.2 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS437;
0.35 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS385a/b;
0.4 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of YGATA_H4;
0.25 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS391
0.45 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS447;
0.2 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS19;
0.25 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS448;
0.4 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS456;
0.45 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS635;
0.6 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS439;
0.8 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS527a/b.
3rd object of the present invention is to provide a kind of DNA test kit.
DNA test kit provided by the invention, comprises above-mentioned primer sets or mentioned reagent.
Above-mentioned primer sets or mentioned reagent are also being the scope of protection of the invention for the preparation of the application detected in the product of sample or sample investigation.
In above-mentioned application, described sample is isolated blood or blood collection card.
Above-mentioned sample investigation is
Experiment of the present invention proves, the present invention is directed to 21 Y-STR sites and design 36 primers, form DNA detection reagent by these primers, PCR damping fluid and DNA enzymatic, 21 Y-STR sites can be checked, and primer specificity is high simultaneously, complete STR somatotype can be obtained, and peak type is sharply clear, balance is good, without Pull-up peak, stutter band, specificity artifact occurs nothing but, can meet the requirement of the extensive Sample of forensic dna completely.Therefore, can use it in extensive sample Y-STR checkout procedure, the effect marking same family sample can be played in the autosomal STR site of high polymorphism, can realize rapid investigation and the differentiation of sample.Improve investigation efficiency, save inspection cost, save proving time.
Accompanying drawing explanation
Fig. 1 is the STR site layout viewing of Y-STR detection reagent
Fig. 2 is the direct augmentation detection that Y-STR testing reagent carries out blood card sample
Embodiment
The experimental technique used in following embodiment if no special instructions, is ordinary method.
Material used in following embodiment, reagent etc., if no special instructions, all can obtain from commercial channels.
The preparation of embodiment 1, Y-STR composite amplification testing reagent
1, the arrangement in Y-STR composite amplification system site
Because Y-STR has patroclinous feature, therefore, the following 21:21 in a site Y-STR site of the DNA inspection of extensive sample investigation is determined.
Above-mentioned 21 Y-STR sites are respectively DYS460, DYS458, DYS389I, DYS438, DYS389II, DYS390, DYS392, DYS393, DYS437, DYS385a/b, YGATA_H4, DYS391, DYS447, DYS19, DYS448, DYS456, DYS635, DYS439, DYS527a/b;
The arrangement mode in its STR site is illustrated in fig. 1 shown below.
2, Y-STR composite amplification system special-purpose amplification primer
According to above-mentioned site design composite amplification primer, primer sequence and concentration as shown in table 1.
Table 1 is composite amplification primer sequence
Amplimer uses FAM respectively, and HEX, TAMRA, ROX tetra-kinds is fluorescein-labelled.
Wherein the amplimer FAM of DYS460, DYS458, DYS389I, DYS438, DYS389II, DYS390, DYS392 marks.
Wherein the amplimer HEX of DYS393, DYS437, DYS385a/b, YGATA_H4 marks.
Wherein the amplimer TAMRA of DYS391, DYS447, DYS19, DYS448 marks.
Wherein the amplimer ROX of DYS456, DYS635, DYS439, DYS527a/b marks.
FAM, HEX, TAMRA, ROX tetra-kinds of fluoresceins are marked at 5 ' end of forward amplimer respectively.
3, the preparation of Y-STR fluorescent composite amplification checking system
The DNA testing reagent investigated for extensive sample is PCR amplification system, specific as follows, and final concentration is below the final concentration in amplification system:
2 × PrimerMix is for mixing the primer of 36 shown in table 1 according to the concentration used table 1 Suo Shi.
The PCR amplification system of every 10 μ L is as follows: 2 μ L5 × PCR damping fluids (final concentration in DNA testing reagent of each material is as shown in table 2), the final concentration of 5 μ L2 × PrimerMix(each bar primer in DNA testing reagent are as shown in table 1), FastSTARDNA polysaccharase (the Roche company of 0.2 μ L5U/ μ L, article No.: 12032902001), all the other supply volume with water.
Table 2 is the component of 5 × PCR damping fluid
PCR Buffer composition | Final concentration |
Tris-HCl | 50mM |
Dntp | 1mM each |
MgCl 2 | 8mM |
BSA | 2mg/mL |
KCl | 250mM |
PCR amplification system is the testing reagent for Y chromosome DNASTR site.
Therefore, DNA testing reagent by having the primer of final concentration shown in table 1, final concentration is 200 μMs of dNTP, final concentration is the MgCl of 1.6mM
2, final concentration is the BSA of 400 μ g/mL, final concentration is 1U/ μ LDNA polysaccharase and water composition.
The application of embodiment 2, Y-STR composite amplification testing reagent
1, sample preparation
Sample is accumulated by the daily DNA database establishment of Material Evidence Identification Center, Ministry of Public Security.Sample is papery type, is blood collection card.
Blood collection card (being known as the male sex) 0.5mm hand-held punch tool is laid a slice disk (being no more than 1.2mm), is placed in 0.2mL thin-walled tube.
2, sample amplification
The DNA testing reagent prepared by embodiment 1 by 10ul adds and is above-mentionedly equipped with in the thin-walled tube of blood collection card, carries out pcr amplification.
Pcr amplification program is: 95 DEG C, 11min; 94 DEG C, 30s, 59 DEG C, 2min, 72 DEG C, 1min, 28 circulations; 60 DEG C, 1h, 25 DEG C, forever.
3, PCR primer detects
Get above-mentioned amplified production 1 μ L and add 10 μ LHi-Di methane amides (ABI company), be placed in ABI3130xl genetic analyzer and carry out capillary electrophoresis detection, concrete operation step is with reference to product description.
Adopt GeneMapperIDv3.2 software to carry out data analysis, its detected result is illustrated in fig. 2 shown below, and above-mentioned sample (male sex) obtains complete STR somatotype, and peak type is sharply clear, balance is good, and without Pull-up peak, stutter band, specificity artifact occurs nothing but.The requirement of the extensive Sample of forensic dna can be met completely.
Therefore, can may be used in extensive sample Y-STR checkout procedure with DNA detection reagent of the present invention, the autosomal STR site of high polymorphism can be played mark and be distinguished the effect of same family Different Individual sample, can realize rapid investigation and the differentiation of sample.Improve investigation efficiency, save inspection cost, save proving time.
Claims (10)
1.DNA checks primer sets, comprises the primer pair group for following 21 Y-STR sites of increasing;
The described primer pair group for following 21 Y-STR sites of increasing is as follows:
For the primer pair of the Y-STR site DYS460 that increases, it is made up of the primer 2 shown in sequence 2 in the primer 1 shown in sequence in sequence table 1 and sequence table;
For the primer pair of the Y-STR site DYS458 that increases, it is made up of the primer 4 shown in sequence 4 in the primer 3 shown in sequence in sequence table 3 and sequence table;
For the primer pair of increase Y-STR site DYS389I or Y-STR site DYS389II, it is made up of the primer 6 shown in sequence 6 in the primer 5 shown in sequence in sequence table 5 and sequence table;
For the primer pair of the Y-STR site DYS438 that increases, it is made up of the primer 8 shown in sequence 8 in the primer 7 shown in sequence in sequence table 7 and sequence table;
For the primer pair of the Y-STR site DYS390 that increases, it is made up of the primer 10 shown in sequence 10 in the primer 9 shown in sequence in sequence table 9 and sequence table;
For the primer pair of the Y-STR site DYS392 that increases, it is made up of the primer 12 shown in sequence 12 in the primer 11 shown in sequence in sequence table 11 and sequence table;
For the primer pair of the Y-STR site DYS393 that increases, it is made up of the primer 14 shown in sequence 14 in the primer 13 shown in sequence in sequence table 13 and sequence table;
For the primer pair of the Y-STR site DYS437 that increases, it is made up of the primer 16 shown in sequence 16 in the primer 15 shown in sequence in sequence table 15 and sequence table;
For Y-STR site DYS385a or the primer pair for the Y-STR site DYS385b that increases of increasing, it is made up of the primer 18 shown in sequence 18 in the primer 17 shown in sequence in sequence table 17 and sequence table;
For the primer pair of the Y-STR site YGATA_H4 that increases, it is made up of the primer 20 shown in sequence 20 in the primer 19 shown in sequence in sequence table 19 and sequence table;
For the primer pair of the Y-STR site DYS391 that increases, it is made up of the primer 22 shown in sequence 22 in the primer 21 shown in sequence in sequence table 21 and sequence table;
For the primer pair of the Y-STR site DYS447 that increases, it is made up of the primer 24 shown in sequence 24 in the primer 23 shown in sequence in sequence table 23 and sequence table;
For the primer pair of the Y-STR site DYS19 that increases, it is made up of the primer 26 shown in sequence 26 in the primer 25 shown in sequence in sequence table 25 and sequence table;
For the primer pair of the Y-STR site DYS448 that increases, it is made up of the primer 28 shown in sequence 28 in the primer 27 shown in sequence in sequence table 27 and sequence table;
For the primer pair of the Y-STR site DYS456 that increases, it is made up of the primer 30 shown in sequence 30 in the primer 29 shown in sequence in sequence table 29 and sequence table;
For the primer pair of the Y-STR site DYS635 that increases, it is made up of the primer 32 shown in sequence 32 in the primer 31 shown in sequence in sequence table 31 and sequence table;
For the primer pair of the Y-STR site DYS439 that increases, it is made up of the primer 34 shown in sequence 34 in the primer 33 shown in sequence in sequence table 33 and sequence table;
For Y-STR site DYS527a or the primer pair for the Y-STR site DYS527b that increases of increasing, it is made up of the primer 36 shown in sequence 36 in the primer 35 shown in sequence in sequence table 35 and sequence table.
2. primer sets according to claim 1, is characterized in that:
Described primer 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, the mol ratio of 36 is 0.12:0.12:0.2:0.2:0.65:0.65:0.45:0.45:0.25:0.25:0.6:0.6: 0.15:0.15:0.2:0.2:0.35:0.35:0.4:0.4:0.25:0.25:0.45:0.45: 0.2:0.2:0.25:0.25:0.4:0.4:0.45:0.45:0.60:0.60:0.80:0.80.
3. primer sets according to claim 2, is characterized in that:
A primer in primer pair described in each all uses fluorescent mark.
4. the primer sets according to Claims 2 or 3, is characterized in that:
5 ' end of the described primer 1 for the Y-STR site DYS460 that increases, for 5 ' end of the primer 3 of the Y-STR site DYS458 that increases, 5 ' end for the primer 5 of increase Y-STR site DYS389I or Y-STR site DYS389II, the 5 ' end for the primer 7 of the DYS438 that increases, the primer 9 for the DYS390 that increases 5 ' end and all mark with FAM for 5 ' end of the primer 11 of the DYS392 that increases;
5 ' end of the described primer 13 for the DYS393 that increases, 5 ' end of the described primer 15 for the DYS437 that increases, described for increasing Y-STR site DYS385a or all mark with HEX for 5 ' end of the primer 17 of the Y-STR site DYS385b that increases, 5 ' end of the described primer 19 for the YGATA_H4 that increases;
5 ' end of the described primer 21 for the DYS391 that increases, 5 ' end of the described primer 23 for the DYS447 that increases, 5 ' end of the described primer 25 for the DYS19 that increases, 5 ' end of the described primer 27 for the DYS448 that increases all mark with TAMRA;
5 ' end of 5 ' end of the described primer 29 for the DYS456 that increases, 5 ' end of the described primer 31 for the DYS635 that increases, the described primer 33 for the DYS439 that increases, described for increasing Y-STR site DYS527a or all mark with ROX for 5 ' end of the primer 35 of the Y-STR site DYS527b that increases.
5. primer sets according to claim 1 and 2, is characterized in that: each bar primer of described primer sets is independent packaging.
6.DNA testing reagent, by described primer sets arbitrary in claim 1-5, dNTP, MgCl
2, BSA, archaeal dna polymerase and water composition.
7. DNA testing reagent according to claim 6, is characterized in that:
Describedly be 0.12 μM for the final concentration of each bar primer in described reagent increased in the primer pair of DYS460;
For the DYS458 that increases primer pair in the final concentration of each bar primer in described reagent be 0.20 μM;
0.65 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS389I or DYS389II;
0.45 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS438;
0.25 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS390;
0.60 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS392;
0.15 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS393;
0.2 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS437;
For increasing Y-STR site DYS385a or be 0.35 μM for the final concentration of each bar primer in described reagent increased in the primer pair of Y-STR site DYS385b;
0.4 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of YGATA_H4;
0.25 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS391
0.45 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS447;
0.2 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS19;
0.25 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS448;
0.4 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS456;
0.45 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS635;
0.6 μM is for the final concentration of each bar primer in described reagent increased in the primer pair of DYS439;
For increasing Y-STR site DYS527a or be 0.8 μM for the final concentration of each bar primer in described reagent increased in the primer pair of Y-STR site DYS527b.
8.DNA test kit, to comprise in claim 1-5 reagent described in arbitrary described primer sets or claim 6 or 7.
9. in claim 1-5 reagent described in arbitrary described primer sets or claim 6 or 7 detect for the preparation of sample Y-STR or investigation product in application.
10. application according to claim 9, is characterized in that: described sample is isolated blood or blood collection card.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410087742.2A CN103866019B (en) | 2014-03-11 | 2014-03-11 | Y-STR fluorescent composite amplification testing reagent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410087742.2A CN103866019B (en) | 2014-03-11 | 2014-03-11 | Y-STR fluorescent composite amplification testing reagent |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103866019A CN103866019A (en) | 2014-06-18 |
CN103866019B true CN103866019B (en) | 2016-02-03 |
Family
ID=50905020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410087742.2A Active CN103866019B (en) | 2014-03-11 | 2014-03-11 | Y-STR fluorescent composite amplification testing reagent |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103866019B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106520973B (en) * | 2016-11-25 | 2019-11-26 | 公安部物证鉴定中心 | A kind of pair of male individual carries out the method and system of quick Y-STR parting |
CN106520980B (en) * | 2016-11-30 | 2019-11-05 | 公安部物证鉴定中心 | A kind of pair of male individual carries out the method and system of Y-STR parting |
CN106755340B (en) * | 2016-11-30 | 2020-07-07 | 公安部物证鉴定中心 | Method and system for carrying out Y-STR typing on male individuals by utilizing 26Y-STR loci |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102260671A (en) * | 2011-07-18 | 2011-11-30 | 公安部物证鉴定中心 | Five-color fluorescent matrix standard substance and preparation method as well as special primer composition thereof |
-
2014
- 2014-03-11 CN CN201410087742.2A patent/CN103866019B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102260671A (en) * | 2011-07-18 | 2011-11-30 | 公安部物证鉴定中心 | Five-color fluorescent matrix standard substance and preparation method as well as special primer composition thereof |
Non-Patent Citations (4)
Title |
---|
17个Y-STR基因座在亲子鉴定中的应用研究;邓志辉等;《中国实验血液学杂志》;20081231;第16卷(第3期);全文 * |
High-throughput Y-STR typing of U.S. populations with 27 regions of the Y chromosome using two multiplex PCR assays;Schoske et al.;《Forensic Sci Int》;20040128;第139卷;摘要、表2 * |
中国Y-STR数据库建设相关问题探讨;葛建业等;《法医学杂志》;20130630;第29卷(第3期);表1 * |
潮汕地区汉族人群20个Y染色体短串联重复序列基因座复合扩增及遗传多态性;石美森等;《中华医学遗传学杂志》;20070630;第24卷(第3期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN103866019A (en) | 2014-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101023170B (en) | Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith | |
Mirhendi et al. | Colony PCR is a rapid and sensitive method for DNA amplification in yeasts | |
Lu et al. | Identification of Pseudallescheria and Scedosporium species by three molecular methods | |
CN104263726A (en) | Primer applied to amplicon sequencing library construction and method for constructing amplicon sequencing library | |
CN104293783A (en) | Primer applicable to amplicon sequencing library construction, construction method, amplicon library and kit comprising amplicon library | |
CN103866019B (en) | Y-STR fluorescent composite amplification testing reagent | |
US20160251709A1 (en) | Direct quantification of unprocessed nucleic acid samples | |
AU2021212731A1 (en) | Improved detection assays | |
CN101432426A (en) | Primer and probe for detection of mycobacterium intracellulare, and method for detection of mycobacterium intracellulare by using the primer and probe | |
CN112725475A (en) | Mycobacterium tuberculosis detection primer, probe composition, kit and application | |
Sun et al. | Database and primer selections affect nematode community composition under different vegetations of Changbai Mountain | |
CN104131100B (en) | Mycobacterium Classification Identification Fluorescence PCR liquid and test kit | |
CN103014171A (en) | Method for analyzing fungus microbial community structure by utilizing specific rDNA long fragment | |
CN103074428A (en) | Mycobacterium tuberculosis TB detection kit | |
CN104911247A (en) | DNA examination reagent for sample examination, and special primer thereof | |
CN109486983A (en) | Buta-buta, Yunnan agalloch eaglewood, Aguilaria malaccensis Lamk SNP marker and application | |
CN107164525A (en) | A kind of DNA for differentiating 6 kinds of Pterocarpus timber combines bar code and its discrimination method and application | |
CN102046788B (en) | Primer and probe for detection of mycobacterium intracellulare, and method for detection of mycobacterium intracellulare using the primer or the probe | |
EP3315612B1 (en) | Set of primers and method for detecting and identifying mussel species of the genus mytilus | |
CN107058522A (en) | Kit and method for detecting mycobacterium tuberculosis and non-tuberculous mycobacteria | |
Stelate et al. | Resolving the phylogenetic relationship between Parmotrema crinitum and Parmotrema perlatum populations | |
CN104531696A (en) | Primer combination and application thereof | |
CN1215179C (en) | Specificity molecule marker of thick wall cell verticil ZK7 strain and its application | |
CN109609668B (en) | Detection primer group and kit for MLVA typing of salmonella typhimurium and application of detection primer group and kit | |
CN107988398A (en) | A kind of method for detecting Escherichia coli nucleic acid and its primer special combination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |